WELLS FARGO & COMPANY/MN - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 123 filers reported holding ENDOLOGIX INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$110,000
-61.7%
154,470
+2.7%
0.00%
Q3 2018$287,000
-63.9%
150,424
+6.8%
0.00%
Q2 2018$796,000
+141.9%
140,822
+81.1%
0.00%
Q1 2018$329,000
-37.0%
77,744
-20.3%
0.00%
Q4 2017$522,000
+5.5%
97,554
-12.0%
0.00%
Q3 2017$495,000
-31.8%
110,900
-25.8%
0.00%
Q2 2017$726,000
-36.5%
149,559
-5.3%
0.00%
Q1 2017$1,144,000
+36.2%
157,990
+7.6%
0.00%
Q4 2016$840,000
-48.6%
146,802
+15.1%
0.00%
-100.0%
Q3 2016$1,633,000
+0.6%
127,557
-2.1%
0.00%0.0%
Q2 2016$1,624,000
+38.0%
130,349
-7.4%
0.00%
Q1 2016$1,177,000
-14.9%
140,739
+0.8%
0.00%
-100.0%
Q4 2015$1,383,000
-89.5%
139,645
-86.9%
0.00%
-80.0%
Q3 2015$13,111,000
-44.5%
1,069,368
-30.5%
0.01%
-44.4%
Q2 2015$23,609,000
-53.9%
1,539,114
-48.7%
0.01%
-10.0%
Q1 2015$51,174,000
+87.9%
2,997,888
+68.3%
0.01%
-9.1%
Q4 2014$27,241,000
+37.9%
1,781,571
-4.4%
0.01%
+37.5%
Q3 2014$19,757,000
-33.7%
1,863,841
-4.8%
0.01%
-33.3%
Q2 2014$29,791,000
+13.0%
1,958,623
-4.4%
0.01%
+9.1%
Q1 2014$26,375,000
-41.8%
2,049,401
-21.1%
0.01%
-45.0%
Q4 2013$45,288,000
-10.9%
2,596,714
-17.5%
0.02%
-16.7%
Q3 2013$50,824,000
-2.8%
3,148,932
-20.1%
0.02%
-11.1%
Q2 2013$52,311,0003,939,1180.03%
Other shareholders
ENDOLOGIX INC shareholders Q4 2014
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,000,000$68,280,0009.00%
Essex Woodlands Management, Inc. 1,257,468$26,843,0005.32%
First Light Asset Management, LLC 277,264$4,733,0002.42%
Lisanti Capital Growth, LLC 175,060$2,988,0001.70%
ArrowMark Colorado Holdings LLC 3,150,275$53,775,0001.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,349,351$40,103,0001.30%
Rail-Splitter Capital Management, LLC 186,076$3,176,0000.97%
WASHINGTON CAPITAL MANAGEMENT, INC 82,316$1,405,0000.81%
Perceptive Advisors 565,000$9,645,0000.75%
PALISADE CAPITAL MANAGEMENT, LP 1,629,329$27,813,0000.70%
View complete list of ENDOLOGIX INC shareholders